2 results match your criteria: "No.2 People's Hospital of Kunming[Affiliation]"
Int J Oncol
November 2017
Department of Respiratory and Critical Medicine, No. 2 People's Hospital of Kunming, Kunming, Yunnan 650204, P.R. China.
Altered microRNA expression has been found to be a common feature of several cancers, including lung carcinomas. However, the possible roles of miR-768-3p in the pathological changes of lung carcinomas are still unknown. The aim of the present study was to investigate the expression and possible effects of miR-768-3p in human non-small cell lung carcinomas (NSCLC).
View Article and Find Full Text PDFJ Cell Biochem
January 2018
Department of Respiratory and Critical Care Medicine, No.2 People's Hospital of Kunming, Kunming, Yunnan Province, P.R. China.
This study aims to explore the influences of Paraoxonase-1 (PON1) involved in airway inflammation and remodeling in asthma. Mice were divided into control, asthma, asthma + PON1 and asthma + NC groups, and asthma models were established via aerosol inhalation of ovalbumin (OVA). HE, Masson, and PAS stains were used to observe airway inflammation and remodeling, Giemsa staining to assess inflammatory cells in bronchoalveolar lavage fluid (BALF), qRT-PCR and Western blot to detect PON1 expression, lipid peroxidation and glutathione assays to quantify malondialdehyde (MDA) activity and glutathione peroxidase (GSH) levels, ELISA to determine inflammatory cytokines and immunoglobulin, and colorimetry to detect PON1 activities.
View Article and Find Full Text PDF